Venetoclax and hypomethylating agent therapy for accelerated and blast phase BCR::ABL negative myeloproliferative and extramedullary disease
- Details
- Publication Year 2023-04,Volume 64,Issue #4,Page 757-760
- Journal Title
- Leukemia & Lymphoma
- Publication Type
- Commentary
- Publisher
- Taylor & Francis
- Keywords
- Humans; *Blast Crisis/drug therapy; *Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Bridged Bicyclo Compounds, Heterocyclic/adverse effects; Sulfonamides/therapeutic use; Fusion Proteins, bcr-abl/genetics
- Department(s)
- Clinical Haematology
- PubMed ID
- 37037568
- Publisher's Version
- https://doi.org/10.1080/10428194.2023.2197533
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2023-08-07 07:16:24
Last Modified: 2023-08-07 07:17:40